Russia has registered the drug Leitragin spray against Covid-19

Photo: hellograndparent.com

Laitragin is the first drug that aims to prevent and fight the cytokine storm caused by Covid-19 in the body.

The Russian Ministry of Health has registered the drug "Leitragin" for the prevention and treatment of pneumonia caused by coronavirus infection, the Russian Agency for Medicine and Biology announced today through its website.

The spray drug Leitragin, developed by the Agency for Medicine and Biology, is registered with the Russian Ministry of Health. It is intended for the prevention and treatment of pneumonia. "The aim is to prevent pneumonia, which is one of the complications of the coronavirus," the agency's website said.

The statement added that the production of the drug is already underway.

Laitragin is the first drug that aims to prevent and fight the cytokine storm caused by Covid-19 in the body.

During the clinical trial, there were no deaths or serious cases among 320 patients with moderate symptoms of Covid-19.

Patients taking Leitragin recovered in an average of eight days, while patients treated with classical methods recovered in 14 days, according to clinical trials.

Dear reader,

Our access to web content is free, because we believe in equality in information, regardless of whether someone can pay or not. Therefore, in order to continue our work, we ask for the support of our community of readers by financially supporting the Free Press. Become a member of Sloboden Pechat to help the facilities that will enable us to deliver long-term and quality information and TOGETHER let's ensure a free and independent voice that will ALWAYS BE ON THE PEOPLE'S SIDE.

SUPPORT A FREE PRESS.
WITH AN INITIAL AMOUNT OF 60 DENARS

Video of the day